Your browser doesn't support javascript.
loading
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
Jia, Hui-Hua; Li, Kai-Wen; Chen, Qin-Yan; Wang, Xue-Yan; Harrison, Tim J; Liang, Shu-Jia; Yang, Qing-Li; Wang, Chao; Hu, Li-Ping; Ren, Chuang-Chuang; Fang, Zhong-Liao.
Afiliación
  • Jia HH; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Li KW; School of Preclinical Medicine, Guangxi Medical University, Nanning, China.
  • Chen QY; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Wang XY; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Harrison TJ; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Liang SJ; Division of Medicine, UCL Medical School, London, United Kingdom.
  • Yang QL; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Wang C; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Hu LP; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Ren CC; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
  • Fang ZL; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.
Intervirology ; 61(3): 123-132, 2018.
Article en En | MEDLINE | ID: mdl-30368502
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Virus de la Hepatitis B / Lamivudine / Farmacorresistencia Viral Múltiple / Coinfección / Hepatitis B Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Virus de la Hepatitis B / Lamivudine / Farmacorresistencia Viral Múltiple / Coinfección / Hepatitis B Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Año: 2018 Tipo del documento: Article